Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMA0076 in ocular hypertension or primary open-angle glaucoma
NCT01693315Phase 2Completed
- Sponsor
- Amakem
- Start
- Sep 2012
- Primary completion
- Jul 2013
- Countries
- 1
01
Overview
A Phase 2 trial of AMA0076 in ocular hypertension, Primary Open Angle Glaucoma (POAG), sponsored by Amakem. Started Sep 2012; status: completed.
02
Drugs
AMA0076
03
Conditions
ocular hypertensionPrimary Open Angle Glaucoma (POAG)
Beyond the preview
Go deeper on NCT01693315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01693315.